BioSpace News Archive

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the expansion of its Boonton, NJ manufacturing facility and the launch of its CDMO business segment

Teva to Present New Long-Term AUSTEDO ® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting Findings evaluate safety, quality of life and patient-centered outcome measures up to 145 weeks

MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Peter Hammerman, M.D., Ph.D., has been appointed as the company’s chief scientific officer.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that two abstracts highlighting data from the pivotal Phase 3 program evaluating the Company’s 3-antigen prophylactic hepatitis B (HBV) vaccine candidate have been accepted for oral and poster presentation at the Canadian Liver Meeting 2021

Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced that it has launched the roadshow for its initial public offering in the United States of up to 6,750,000 American Depositary Shares (“ADSs”) representing 6,750,000 ordinary shares.

Mednow Inc., Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting a webcast investor presentation on Tuesday, May 4, 2021 at 1pm ET.

OpRegen ® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy Eighty-Three Percent of All Cohort 4 Patients Exhibited Stable or Improved BCVA Visual Acuity Declined in the Majority of Untreated Eyes

SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders, announced , on “Melanoma Monday”, their joint efforts with Advanced Dermatology and Cosmetic Surgery - the premier dermatology network in the US with over 150 practices - to raise awareness of melanoma and educate around the dangers of the fastest growing and most deadly form of skin cancer to commemorate Skin Cancer Awareness Month.

Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, will release financial results for the first quarter ended March 31st, 2021 after market close on Wednesday, May 12th, 2021.

Align Technology, Inc. announced that it has entered into an accelerated stock repurchase agreement with Goldman Sachs & Co LLC, to repurchase $100 million of Align’s common stock to complete its $600 million stock repurchase program announced on May 23, 2018.